Par Drugs and Share Price History and Returns 2019 to 2026
|
Par Drugs and Chemicals Limited |
|||
|
Price: ₹93.40 (7.75%) | ||
| 52 Week Low: ₹78.05 52 Week High: ₹122.43 |
|||
| Market Capital: 135.57 Crore (Small-cap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Par Drugs and Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Par Drugs and Recent Performance
- 3: Par Drugs and Stock Price Chart From 2019 to 2026
- 4: Par Drugs and Stock Price History Table From 2019 to 2026
- 5: Analyzing the Impact of Investing in Par Drugs and
- 5.1: Par Drugs and Stock Returns In Last 5 Years
- 6: Par Drugs and Returns vs Bank FD Returns
Par Drugs and Stock Highlights
As of 15 Jun 2026, Par Drugs and Stock price is ₹93.40 which is ₹29.03 below 52-week high of ₹122.43 and ₹15.35 above 52-week low of ₹78.05
52-Week High Low
- Par Drugs and 52-Week High is ₹122.43 occurred on 18 Sep 2025
- Par Drugs and 52-Week Low is ₹78.05 occurred on 30 Mar 2026
All Time High
- The all-time high or the highest price that Par Drugs and stocks have ever touched was ₹348.45 and this occurred on Dec 2024.
- The highest closing price at which Par Drugs and stocks have ever closed was ₹294.70 recorded on Oct 2024.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Par Drugs and Recent Performance
Over the past 15 trading days, the value of Par Drugs and's stock has increased by ₹1.13 (+1.22%). On 25 May 2026, its one share was worth ₹92.27 and by 15 Jun 2026, the value jumped to ₹93.4. During this period it created a highest high of ₹98.00 and lowest low of ₹82.90.
Click on legend items to show/hide respective price lines
Par Drugs and Stock Price Chart From 2019 to 2026
Click on legend items to show/hide respective price lines
Par Drugs and Stock Price History Table From 2019 to 2026
| Year | Par Drugs and | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2026 | ₹86.68 | -14.4% |
↑ ₹105.00 ↓ ₹78.05 |
| 2025 | ₹101.26 | -49.1% |
↑ ₹220.00 ↓ ₹81.01 |
| 2024 | ₹198.90 | -7.8% |
↑ ₹348.00 ↓ ₹190.00 |
| 2023 | ₹215.70 | 42.8% |
↑ ₹248.00 ↓ ₹128.00 |
| 2022 | ₹151.05 | -25.0% |
↑ ₹205.00 ↓ ₹131.00 |
| 2021 | ₹201.25 | 451.3% |
↑ ₹310.00 ↓ ₹31.20 |
| 2020 | ₹36.50 | 65.5% |
↑ ₹37.40 ↓ ₹13.10 |
| 2019 | ₹22.05 | - |
↑ ₹28.00 ↓ ₹19.45 |
Analyzing the Impact of Investing in Par Drugs and
Par Drugs and Stock price in the year 2019 was ₹22.05. If you had invested ₹10,000 in Par Drugs and Stock in 2019, in 7 years, your investment would have grown to ₹39,310 by the end of 2026. This represents a positive return of 293% from 2019 to 2026, with a compound annual growth rate (CAGR) of 21.5%.
Par Drugs and Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹348.45 and lowest was: ₹31.20
- Par Drugs and Stock price in 2021 was ₹201.25
- By 2026, its stock price dropped to ₹86.68
- It gave a negative return of over -56.9% with a CAGR of -15.5% over the last 5 years
- If you had invested ₹10,000 in Par Drugs and in 2021 then in 5 years, your investment would have declined to ₹4,307.08 by 2026.
Par Drugs and Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| Par Drugs and Shares | ₹10,000 | ₹39,310.65 | 293.1% |
| Bank FD (Simple Interest) | ₹10,000 | ₹14,200 | 42.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹15,036.3 | 50.4% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
